The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives
Open accessAbstract
Paclitaxel is an antineoplastic agent derived from the bark of the western yew, Taxus brevifolia, with a broad spectrum of activity. Because paclitaxel promotes microtubule assembly, neurotoxicity is one of its side effects. Clinical use of paclitaxel has led to peripheral neuropathy and this has been demonstrated to be dependent upon the dose administered, the duration of the infusion, and the schedule of administration. Vehicles in the drug formulation, for example Cremophor in Taxol, have been investigated for their potential to induce peripheral neuropathy. A variety of neuroprotective agents have been tested in animal and clinical studies to prevent paclitaxel neurotoxicity. Recently, novel paclitaxel formulations have been developed to minimize toxicities. This review focuses on recent advances in the etiology of paclitaxel-mediated peripheral neurotoxicity, and discusses current and ongoing strategies for amelioration of this side effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,796
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
Self-citationPiccart, M. J. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.699 · Cited by 981
Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H., & van Tellingen, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2031 · Cited by 882
Self-citationKim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Clinical toxicities encountered with paclitaxel (Taxol).
Rowinsky, E. K., Eisenhauer, E. A., Chaudhry, V., Sg, A., & Rc, D. (1993) · PubMed · Cited by 692
Eisenhauer, E. A., ten Bokkel Huinink, W. W., Swenerton, K. D., Gianni, L., Myles, J., van der Burg, M. E., Kerr, I., Vermorken, J. B., Buser, K., & Colombo, N. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2654 · Cited by 626
Central Nervous System Toxicity after Liver Transplantation
de Groen, P. C., Aksamit, A. J., Rakela, J., Forbes, G. S., & Krom, R. A. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710013171404 · Cited by 498
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
Polomano, R. C., Mannes, A. J., Clark, U. S., & Bennett, G. J. (2001) · Pain · doi:10.1016/s0304-3959(01)00363-3 · Cited by 476
Phase I clinical and pharmacokinetic study of taxol.
Wiernik, P. H., Schwartz, E. L., Strauman, J. J., Dutcher, J. P., Lipton, R. B., & Paietta, E. M. (1987) · PubMed · Cited by 455
Hensley, M. L., Schuchter, L., Lindley, C., Meropol, N., Cohen, G., Broder, G., Gradishar, W., Green, D., Langdon, R., Mitchell, R. B., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3333 · Cited by 335
Taxol produces a predominantly sensory neuropathy
Lipton, R. B., Apfel, S. C., Dutcher, J. P., Rosenberg, R., Kaplan, J., Berger, A., Einzig, A. I., Wiernik, P., & Schaumburg, H. H. (1989) · Neurology · doi:10.1212/wnl.39.3.368 · Cited by 318
Yuhas, J. M. (1980) · PubMed · Cited by 294
Role of Formulation Vehicles in Taxane Pharmacology
van Zuylen, L., Verweij, J., & Sparreboom, A. (2001) · Investigational New Drugs · doi:10.1023/a:1010618632738 · Cited by 293
Self-citationThe role of WR-2721 in radiotherapy and/or chemotherapy.
Yuhas, J. M., Spellman, J. M., & Čulo, F. (1980) · PubMed · Cited by 281
Postma, T. J., Vermorken, J. B., Liefting, A. J. M., Pinedo, H. M., & Heimans, J. J. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059220 · Cited by 271
Winer, E. P., Berry, D. A., Woolf, S., Duggan, D., Kornblith, A., Harris, L. N., Michaelson, R. A., Kirshner, J. A., Fleming, G. F., Perry, M. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.048 · Cited by 270
Nerve growth factor prevents toxic neuropathy in mice
Apfel, S. C., Lipton, R. B., Arezzo, J. C., & Kessler, J. A. (1991) · Annals of Neurology · doi:10.1002/ana.410290115 · Cited by 241
Nerve growth factor prevents experimental cisplatin neuropathy
Apfel, S. C., Arezzo, J. C., Lipson, L., & Kessler, J. A. (1992) · Annals of Neurology · doi:10.1002/ana.410310114 · Cited by 210
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial
Argyriou, A. A., Chroni, E., Koutras, A., Ellul, J., Papapetropoulos, S., Katsoulas, G., Iconomou, G., & Kalofonos, H. P. (2005) · Neurology · doi:10.1212/01.wnl.0000148609.35718.7d · Cited by 209
Rowinsky, E. K., Chaudhry, V., Cornblath, D. R., & Donehower, R. C. (1993) · PubMed · Cited by 208
Axonal Transport: Components, Mechanisms, and Specificity
Schwartz, J. H. (1979) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.02.030179.002343 · Cited by 205
Inhibition of neurite initiation and growth by taxol.
Letourneau, P. C., & Ressler, A. H. (1984) · The Journal of cell biology · doi:10.1083/jcb.98.4.1355 · Cited by 195
Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.
Pisano, C., Pratesi, G., Laccabue, D., Zunino, F., Giudice, P. L., Bellucci, A., Pacifici, L., Camerini, B., Vesci, L., Castorina, M., et al. (2003) · PubMed · Cited by 181
Sarosy, G., Kohn, E., Stone, D. A., Rothenberg, M., Jacob, J., Adamo, D. O., Ognibene, F. P., Cunnion, R. E., & Reed, E. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1165 · Cited by 179
Description of a short-term Taxol®-induced nociceptive neuropathy in rats
Authier, N., Gillet, J.-P., Fialip, J., Eschalier, A., & Coudore, F. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02910-3 · Cited by 171
Insulin-like Growth Factor-I: Potential for Treatment of Motor Neuronal Disorders
Lewis, M. E., Neff, N. T., Contreras, P. C., Stong, D. B., Oppenheim, R. W., Grebow, P. E., & Vaught, J. L. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1177 · Cited by 169
Cavaletti, G., Cavalletti, E., Oggioni, N., Sottani, C., Minoia, C., D’Incalci, M., Zucchetti, M., Marmiroli, P., & Tredici, G. (2000) · PubMed · Cited by 167
Cavaletti, G., Cavalletti, E., Oggioni, N., Sottani, C., Minoia, C., D’Incalci, M., Zucchetti, M., Marmiroli, P., & Tredici, G. (2001) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2001.01008-5.x · Cited by 157
Smith, R. E., Brown, A. M., Mamounas, E. P., Anderson, S., Lembersky, B. C., Atkins, J. H., Shibata, H. R., Báez, L., DeFusco, P. A., Davila, E., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3403 · Cited by 151
Motor neuropathy due to docetaxel and paclitaxel
Freilich, R. J., Balmaceda, C. M., Seidman, A. D., Rubin, M., & DeAngelis, L. M. (1996) · Neurology · doi:10.1212/wnl.47.1.115 · Cited by 144
Mielke, S., Sparreboom, A., Steinberg, S. M., Gelderblom, H. A. J., Unger, C., Behringer, D. M., & Mross, K. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0298 · Cited by 144
Self-citationGrowth Cone Motility And Guidance
Bray, D., & Hollenbeck, P. J. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.000355 · Cited by 136
Physiological characterization of taxol‐induced large‐fiber sensory neuropathy in the rat
Cliffer, K. D., Siuciak, J. A., Carson, S. R., Radley, H. E., Park, J. S., Lewis, D. R., Zlotchenko, E., Nguyen, T. T. T., García, K., Tonra, J. R., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430111 · Cited by 131
Peripheral neurotoxicity of taxol in patients previously treated with cisplatin
Cavaletti, G., Bogliun, G., Marzorati, L., Zincone, A., Marzola, M., Colombo, N., & Tredici, G. (1995) · Cancer · doi:10.1002/1097-0142(19950301)75:5<1141::aid-cncr2820750514>3.0.co;2-u · Cited by 119
A role of microtubules during the formation of cell processes in neuronal and non-neuronal cells
Kobayashi, N., & Mundel, P. H. (1998) · Cell and Tissue Research · doi:10.1007/s004410050988 · Cited by 118
Potential neurotoxicity of the solvent vehicle for cyclosporine.
Windebank, A. J., Blexrud, M. D., & de Groen, P. C. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38962-7 · Cited by 105
Alternative formulations of paclitaxel
Terwogt, J. M. M., Nuijen, B., Huinink, W. W. T. B., & Beijnen, J. H. (1997) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(97)90022-0 · Cited by 100
Connelly, E. F., Markman, M. M., KENNEDY, A. W., Webster, K. D., Kulp, B., Peterson, G., & Belinson, J. L. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0210 · Cited by 98
Progress in the Development of Alternative Pharmaceutical Formulations of Taxanes
Nuijen, B., Bouma, M., Schellens, J. H. M., & Beijnen, J. H. (2001) · Investigational New Drugs · doi:10.1023/a:1010682916808 · Cited by 96
Microtubule arrays in taxol-treated mouse dorsal root ganglion-spinal cord cultures
Masurovsky, E. B., Peterson, E. R., Crain, S. M., & Horwitz, S. B. (1981) · Brain Research · doi:10.1016/0006-8993(81)90017-2 · Cited by 93
THE ROLE OF MICROTUBULES IN THE GROWTH AND STABILIZATION OF NERVE FIBERS
Daniels, M. P. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb19227.x · Cited by 91
Taxol-induced neuropathy: short-term effects of local injection
R�ytt�, M., Horwitz, S. B., & Raine, C. S. (1984) · Journal of Neurocytology · doi:10.1007/bf01148489 · Cited by 91
Peterson, E. R., & Crain, S. M. (1982) · Science · doi:10.1126/science.6124041 · Cited by 82
Comparative Pharmacokinetics of Unbound Paclitaxel During 1- and 3-Hour Infusions
Gelderblom, H. A. J., Mross, K., ten Tije, A. J., Behringer, D. M., Mielke, S., van Zomeren, D. M., Verweij, J., & Sparreboom, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.574 · Cited by 82
Self-citationTaxol-induced neuropathy: chronic effects of local injection
Röyttä, M., & Raine, C. S. (1986) · Journal of Neurocytology · doi:10.1007/bf01611731 · Cited by 81
Amelioration of Experimental Cisplatin and Paclitaxel Neuropathy with Glutamate
Boyle, F. M., Wheeler, H., & Shenfield, G. M. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006124917643 · Cited by 79
Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel
Openshaw, H., Beamon, K., Synold, T. W., Longmate, J., Slatkin, N. E., Doroshow, J. H., Forman, S. J., Margolin, K. A., Morgan, R. J., Shibata, S., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0772-03 · Cited by 78
Paclitaxel (Taxol) induces cumulative mild neurotoxicity
van Gerven, J., Moll, J. W. B., van den Bent, M. J., Bontenbal, M., van der Burg, M. E. L., Verweij, J., & Vecht, C. J. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90459-6 · Cited by 77
Masurovsky, E. B., Peterson, E. R., Crain, S. M., & Horwitz, S. B. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90148-3 · Cited by 75
Hayakawa, K., Sobue, G., Itoh, T., & Mitsuma, T. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00744-6 · Cited by 70
Lesser, G. J., Grossman, S. A., Eller, S., & Rowinsky, E. K. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685646 · Cited by 48
Brat, D. J., Aj, W., & Brimijoin, S. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11107-5 · Cited by 38
Paclitaxel neurotoxicity: clinical and neurophysiological study of 23 patients
Pace, A., Bove, L., Aloe, A., Nardi, M., Pietrangeli, A., Calabresi, F., Innocenti, P., & Jandolo, B. (1997) · Neurological Sciences · doi:10.1007/bf01999566 · Cited by 33
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial
Pace, A., Bove, L., & Jandolo, B. (2005) · Neurology · doi:10.1212/wnl.65.3.501 · Cited by 28
The acute effects of taxol upon regenerating axons after nerve crush
Vuorinen, V., R�ytt�, M., & Raine, C. S. (1988) · Acta Neuropathologica · doi:10.1007/bf00687677 · Cited by 23
The acute response of Schwann cells to taxol after nerve crush
Vuorinen, V., R�ytt�, M., & Raine, C. S. (1988) · Acta Neuropathologica · doi:10.1007/bf00687676 · Cited by 17
Cited by
Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., Chauhan, C., Gavin, P., Lavino, A., Lustberg, M. B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.0914 · Cited by 1,209
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Zajączkowska, R., Kocot-Kępska, M., Leppert, W., Wrzosek, A., Mika, J., & Wordliczek, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061451 · Cited by 829
Socinski, M. A., Bondarenko, I., Karaseva, N. A., Makhson, A. M., Vynnychenko, I., Okamoto, I., Hon, J. K., Hirsh, V., Bhar, P., Zhang, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5848 · Cited by 756
Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
Areti, A., Yerra, V. G., Naidu, V., & Kumar, A. (2014) · Redox Biology · doi:10.1016/j.redox.2014.01.006 · Cited by 456
Chemotherapy-induced neuropathy: A comprehensive survey
Miltenburg, N. C., & Boogerd, W. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.04.004 · Cited by 431
Metadata
- Authors
- Scripture, C., Figg, W., & Sparreboom, A.
- Venue
- Current Neuropharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2006-04-01
- Volume
- 4
- Issue
- 2
- Pages
- 165-172
- ISSN
- 1570-159X (ISSN-L)
- OpenAlex
- W2005452896
- Cited by
- 320
- References
- 58
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.